Behavioral Exposure Therapy for Exercise Intolerance
(BE-FIT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate how a new treatment, Behavioral Exposure for Interoceptive Tolerance (BE-FIT), can reduce exercise anxiety in individuals undergoing cardiac rehabilitation. BE-FIT involves acclimating to exercise-related sensations, avoiding habits that might impede progress, and using a Fitbit to track activity and set goals. The trial will compare BE-FIT to a health education program to determine which is more effective in improving exercise habits. Individuals medically approved for cardiac rehab and experiencing high levels of exercise anxiety might be suitable candidates for this trial. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to significant findings.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Behavioral Exposure for Interoceptive Tolerance (BE-FIT) is safe for participants. Previous studies found that BE-FIT is not only feasible and acceptable but also easy for participants to manage. Participants experienced less anxiety about exercise, and no serious side effects occurred. This suggests that the treatment is safe, particularly in helping individuals manage exercise-related anxiety.12345
Why are researchers excited about this trial?
Researchers are excited about the Behavioral Exposure Therapy for Exercise Intolerance because it targets exercise anxiety in a unique way. Unlike standard treatments that might focus solely on fitness or physical activity levels, this approach integrates cognitive-behavioral strategies to directly address fears related to exercise. The therapy includes exposure to feared bodily sensations, discourages safety behaviors, and uses a Fitbit to provide real-time feedback and help set activity goals. This comprehensive method aims to not only improve physical endurance but also reduce anxiety, making it a promising alternative for those struggling with exercise intolerance.
What evidence suggests that the BE-FIT intervention is effective for reducing exercise anxiety in cardiac rehabilitation patients?
Research shows that the BE-FIT program, which participants in this trial may receive, can help reduce anxiety about exercising. In earlier studies, participants increased their physical activity, such as taking more steps each day and engaging in more moderate-to-vigorous exercise. The program involves confronting feelings that make exercise intimidating, avoiding habits that provide false security, and wearing a wrist monitor for feedback and activity goal setting. These steps aim to help participants feel more comfortable with exercise over time. Early results suggest that BE-FIT is safe, well-received, and effective in helping people maintain their exercise routines.12356
Are You a Good Fit for This Trial?
This trial is for individuals over 40 with high exercise anxiety, approved for cardiac rehab, and not very active. They must speak English and have no severe cognitive impairments or chronic conditions that could interfere with the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the BE-FIT intervention or Health Education Control over 6 individual sessions delivered twice weekly during the initial weeks of outpatient cardiac rehabilitation
Follow-up
Participants are monitored for exercise adherence and anxiety reduction with assessments at baseline, end of treatment, and three follow-up points
What Are the Treatments Tested in This Trial?
Interventions
- Behavioral Exposure For Introceptive Tolerance
- Health Education Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor
National Institute on Aging (NIA)
Collaborator